HealthDay News — For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to ...

Eleven-point-four percent of patients who underwent liver transplantation for cirrhosis developed cirrhosis subsequent to transplant.

The investigational mannose-1-phosphate replacement therapy aims to restore metabolic function and improve neurological outcomes in pediatric and adult patients.

In the phase 3 OASIZ 301 trial, the investigational drug dazodalibep significantly reduced systemic disease activity in patients with moderate to severe Sjögren disease compared with placebo.

The kratom leaf contains only trace amounts of this compound naturally. Unlike kratom’s main ingredient, 7-OH acts directly on opioid receptors in the brain, so its effects can be stronger and more ...

Colonoscopy at 5 vs 3 years after polyp removal noninferior for colorectal cancer cumulative incidence at 5 years.

Estimated four-year event-free survival significantly higher in patients receiving blinatumomab vs traditional chemotherapy.

Monthly subcutaneous sefaxersen significantly reduced proteinuria compared with placebo at week 37 in patients with primary IgA nephropathy at high risk of disease progression.

Charles Bonnet syndrome affects about 1 in 6 people with serious vision loss, and experts say talking about it early eases fear ...

High amounts of egg and peanut during pregnancy and lactation do not result in lower risk for development of allergy in infants.

HealthDay News — Menopausal hormone therapy (MHT) initiation in perimenopausal or recently postmenopausal women with vasomotor symptoms may reduce cardiovascular disease (CVD) risk, with more ...

Topline phase 3 findings show the KIT receptor inhibitor barzolvolimab significantly reduced itch and hives while achieving high complete response rates in patients with chronic spontaneous urticaria.